Source:http://linkedlifedata.com/resource/pubmed/id/11139682
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2001-2-2
|
pubmed:abstractText |
We report a case of non-alcoholic steatohepatitis with cirrhosis in a woman receiving tamoxifen as adjuvant treatment for breast cancer. Despite the presence of other risk factors for non-alcoholic steatohepatitis (such as diabetes, obesity and hyperlipidemia), the patient developed non-alcoholic steatohepatitis and cirrhosis only after tamoxifen was started. We suggest that patients receiving tamoxifen, especially patients with predisposing metabolic disorders, should be evaluated for non-alcoholic steatohepatitis, because progression to cirrhosis may occur.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0399-8320
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1122-3
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11139682-Aged,
pubmed-meshheading:11139682-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11139682-Drug-Induced Liver Injury,
pubmed-meshheading:11139682-Fatty Liver,
pubmed-meshheading:11139682-Female,
pubmed-meshheading:11139682-Humans,
pubmed-meshheading:11139682-Iatrogenic Disease,
pubmed-meshheading:11139682-Liver,
pubmed-meshheading:11139682-Liver Cirrhosis,
pubmed-meshheading:11139682-Tamoxifen
|
pubmed:year |
2000
|
pubmed:articleTitle |
[Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
|
pubmed:affiliation |
Service de Gastroentérologie, Proctologie et Médecine Interne, Fondation Hôpital Saint-Joseph, Paris.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|